Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

ClinicalTrials.gov ID: NCT00278824

Public ClinicalTrials.gov record NCT00278824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate the Efficacy of CHADD™ Applied Over a Transdermal Fentanyl Patch for the Treatment of Breakthrough Pain in Patients With Moderate to Severe Non-malignant Chronic Pain

Study identification

NCT ID
NCT00278824
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
ZARS Pharma Inc.
Industry
Enrollment
109 participants

Conditions and interventions

Conditions

Interventions

  • Matrix Transdermal Fentanyl/CHADD Drug Delivery System Drug
  • Placebo Patch Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
Jul 31, 2006
Completion
Jul 31, 2006
Last update posted
Jun 4, 2012

2006

United States locations

U.S. sites
15
U.S. states
14
U.S. cities
15
Facility City State ZIP Site status
Arizona Reserach Center Phoenix Arizona 85023
Florida's Institute of Clinical Research Jacksonville Florida 32207
Drug Studies America Marietta Georgia 30060
Pain & Rehabilitation Clinic of Chicago Chicago Illinois 60610
Integrated Clinical Trial Services, Inc. West Des Moines Iowa 50265
Brigham & Women's Hospital Boston Massachusetts 02115
Medical Advanced Pain Specialists Minneapolis Minnesota 55433
Pain Management Associates Independence Missouri 64055
Analgesic Development Ltd. New York New York 10022
Southeast Research Institute Charlotte North Carolina 28203
The Center for Clinical Research Winston-Salem North Carolina 27103
Pain Consultants of Oregon, PC Eugene Oregon 97401
Allegheny Pain Management Altoona Pennsylvania 16602
Lifetree Clinical Research Salt Lake City Utah 84106
Advanced Pain Management Virginia Beach Virginia 23454

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00278824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00278824 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →